Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

31.160
+0.9603.18%
Volume:33.90K
Turnover:1.04M
Market Cap:4.18B
PE:-28.07
High:31.500
Open:30.500
Low:29.500
Close:30.200
52wk High:33.800
52wk Low:13.480
Shares:134.00M
HK Float Shares:134.00M
Volume Ratio:1.55
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.110
ROE:-27.27%
ROA:-12.63%
PB:5.13
PE(LYR):-28.07
PS:38894.25

Loading ...

HANXBIO-B (03378) Allocates HK$988,500 for Share Buyback on April 22

Stock News
·
Apr 22

Hanx Biopharma buys back 2,100 H-shares; treasury stock climbs to 246,000

Bulletin Express
·
Apr 21

Hanx Biopharmaceuticals Triggers Share Buyback; 23,000 H Shares Repurchased for HKD 0.68 Million

Bulletin Express
·
Apr 17

HANXBIO-B (03378) Repurchases 23,000 Shares for HK$684,600 on April 17

Stock News
·
Apr 17

Hanx Biopharmaceuticals Completes HKD 0.59 Million Share Buyback, Lifting Treasury Shares to 220,900

Bulletin Express
·
Apr 16

HANXBIO-B Allocates Approximately HK$619,900 for Share Buyback on April 15

Deep News
·
Apr 16

Hanx Biopharmaceuticals buys back 21,500 H-shares, treasury stock rises to 200,800

Bulletin Express
·
Apr 15

HANXBIO-B (03378) Repurchases 23,500 Shares for HK$683,100 on April 14

Stock News
·
Apr 14

Hanx Biopharmaceuticals executes HK$0.72 million share buyback, raises treasury stock to 109,800 shares

Bulletin Express
·
Apr 14

Hanx Biopharmaceuticals completes HKD 1.37 million share buyback, boosts treasury stock to 155,800 H-shares

Bulletin Express
·
Apr 14

HANXBIO-B Buys Back 43,000 H Shares; Treasury Stock Rises to 149,100 Shares

Bulletin Express
·
Apr 13

HANXBIO-B (03378) Repurchases 43,000 Shares for HK$1.29 Million on April 13

Stock News
·
Apr 13

Hanx Biopharmaceuticals Announces Four Oncology Poster Presentations for AACR 2026

Bulletin Express
·
Apr 10

HANXBIO-B repurchases 20,000 H shares at HK$30.13 average, boosting treasury stock to 106,100 shares

Bulletin Express
·
Apr 10

HANXBIO-B (03378) to Present Four Poster Research Findings at 2026 AACR Annual Meeting

Stock News
·
Apr 10

Hanx Biopharmaceuticals to present four preclinical cancer drug studies at AACR 2026

Reuters
·
Apr 10

HANXBIO-B (03378) Spends HK$32,100 on Share Buyback of 1,100 Shares on April 9

Stock News
·
Apr 09

HANXBIO-B (03378) Repurchases 41,400 Shares for Approximately HK$1.32 Million on April 8

Stock News
·
Apr 08

Hanx Biopharmaceuticals repurchases 41,400 H-shares; treasury stock increases to 85,000

Bulletin Express
·
Apr 08

HANXBIO-B (03378) Spends HK$1.28 Million on Share Buyback on March 31

Stock News
·
Mar 31